{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T16:04:03Z","timestamp":1720109043729},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.amjcard.2005.06.026","type":"journal-article","created":{"date-parts":[[2005,7,15]],"date-time":"2005-07-15T09:34:03Z","timestamp":1121420043000},"page":"45-53","source":"Crossref","is-referenced-by-count":20,"special_numbering":"S","title":["The Case for Intensive Statin Therapy After Acute Coronary Syndromes"],"prefix":"10.1016","volume":"96","author":[{"given":"Gregory G.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders G.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2005.06.026_bib1","series-title":"2002 Heart and Stroke Statistical Update","year":"2001"},{"key":"10.1016\/j.amjcard.2005.06.026_bib2","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.026_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.026_bib4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary-artery disease","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.06.026_bib5","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.026_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0002-9149(92)90495-K","article-title":"Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography","volume":"69","author":"Giroud","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.06.026_bib7","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.06.026_bib8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.026_bib9","first-page":"1349","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"39","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.026_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.06.026_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.CIR.90.2.775","article-title":"Macrophage infiltration in acute coronary syndromes","volume":"90","author":"Moreno","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.026_bib13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/01.CIR.0000088521.04017.13","article-title":"Soluble CD40L","volume":"108","author":"Varo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ahj.2004.07.041","article-title":"Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome","volume":"149","author":"Macin","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2005.06.026_bib15","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1182\/blood-2003-11-3791","article-title":"Evidence for anti-inflammatory activity of statins and PPAR\u03b1 activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro","volume":"103","author":"Kleemann","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.amjcard.2005.06.026_bib16","doi-asserted-by":"crossref","first-page":"R1253","DOI":"10.1152\/ajpregu.00170.2003","article-title":"C-reactive protein and atherothrombosis\u2014beyond a biomarker","volume":"285","author":"Verma","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.amjcard.2005.06.026_bib17","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.CIR.0000029743.68247.31","article-title":"Simvastatin lowers C-reactive protein within 14 days","volume":"106","author":"Plenge","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.90.1.5","article-title":"Vasoreactivity of the culprit lesion in unstable angina","volume":"90","author":"Bogaty","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib20","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1161\/hc2401.092816","article-title":"Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease","volume":"103","author":"Vasa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","article-title":"Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month","volume":"95:","author":"O\u2019Driscoll","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.CIR.95.1.76","article-title":"Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans","volume":"95","author":"Tamai","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease","volume":"332","author":"Treasure","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.026_bib24","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.102.8.846","article-title":"Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease","volume":"102","author":"Vita","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib25","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/01.CIR.95.6.1370","article-title":"Low-density lipoproteins inhibit the Na+\/H+ antiport in human platelets","volume":"95","author":"Nofer","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0021-9150(98)00144-0","article-title":"Effects of lipids and lipoproteins on thrombosis and rheology","volume":"140","author":"Rosenson","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2005.06.026_bib27","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1161\/01.CIR.92.11.3172","article-title":"Hyperlipidemia and coronary disease","volume":"92","author":"Lacoste","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0021-9150(99)00291-9","article-title":"Inhibition of tissue-factor-mediated thrombin generation by simvastatin","volume":"149","author":"Ferro","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2005.06.026_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.ATV.15.2.247","article-title":"Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia","volume":"15","author":"Notarbartolo","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2005.06.026_bib30","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib31","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes","volume":"290","author":"Nissen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.06.026_bib32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/jama.285.4.430","article-title":"Early statin treatment following acute myocardial infarction and 1-year survival","volume":"285","author":"Stenestrand","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.06.026_bib33","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(00)04257-4","article-title":"Effect of lipid-lowering therapy on early mortality after acute coronary syndromes","volume":"357","author":"Aronow","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.06.026_bib34","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1001\/jama.287.23.3087","article-title":"Early statin initiation and outcomes in patients with acute coronary syndromes","volume":"287","author":"Newby","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.06.026_bib35","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ahj.2003.10.052","article-title":"Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina","volume":"148","author":"Thompson","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2005.06.026_bib36","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1053\/euhj.2002.3291","article-title":"Effect of fluvastatin on ischaemia following acute myocardial infarction","volume":"23","author":"Liem","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2005.06.026_bib37","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.06.026_bib38","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.06.026_bib39","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.06.026_bib40","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.0000031568.40630.1C","article-title":"Effects of atorvastatin on stroke in patients with unstable angina or non\u2013Q-wave myocardial infarction","volume":"106","author":"Waters","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.CIR.103.3.387","article-title":"Reduction of stroke events with pravastatin","volume":"103","author":"Byington","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib42","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/eurheartj\/ehi186","article-title":"High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome","volume":"26","author":"Olsson","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2005.06.026_bib43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.CIR.0000136588.62638.5E","article-title":"Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study","volume":"110","author":"Kinlay","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib44","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/01.CIR.0000091404.09558.AF","article-title":"High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study","volume":"108","author":"Kinlay","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib45","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9149(03)00820-8","article-title":"Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients","volume":"92","author":"Newman","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.06.026_bib46","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.06.026_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.103.1.38","article-title":"Use of lipid-lowering medications at discharge in patients with acute myocardial infarction","volume":"103","author":"Fonarow","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.06.026_bib48","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/archinte.164.21.2343","article-title":"Impact of concurrent medication use on statin adherence and refill persistence","volume":"164","author":"Grant","year":"2004","journal-title":"Arch Intern Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905010842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905010842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T09:20:17Z","timestamp":1548321617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914905010842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0002914905010842"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2005.06.026","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}